Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 19;23(8):4106.
doi: 10.3390/s23084106.

Electrochemical and Photoelectrochemical Immunosensors for the Detection of Ovarian Cancer Biomarkers

Affiliations
Review

Electrochemical and Photoelectrochemical Immunosensors for the Detection of Ovarian Cancer Biomarkers

Ezinne U Ekwujuru et al. Sensors (Basel). .

Abstract

Photoelectrochemical (PEC) sensing is an emerging technological innovation for monitoring small substances/molecules in biological or non-biological systems. In particular, there has been a surge of interest in developing PEC devices for determining molecules of clinical significance. This is especially the case for molecules that are markers for serious and deadly medical conditions. The increased interest in PEC sensors to monitor such biomarkers can be attributed to the many apparent advantages of the PEC system, including an enhanced measurable signal, high potential for miniaturization, rapid testing, and low cost, amongst others. The growing number of published research reports on the subject calls for a comprehensive review of the various findings. This article is a review of studies on electrochemical (EC) and PEC sensors for ovarian cancer biomarkers in the last seven years (2016-2022). EC sensors were included because PEC is an improved EC; and a comparison of both systems has, expectedly, been carried out in many studies. Specific attention was given to the different markers of ovarian cancer and the EC/PEC sensing platforms developed for their detection/quantification. Relevant articles were sourced from the following databases: Scopus, PubMed Central, Web of Science, Science Direct, Academic Search Complete, EBSCO, CORE, Directory of open Access Journals (DOAJ), Public Library of Science (PLOS), BioMed Central (BMC), Semantic Scholar, Research Gate, SciELO, Wiley Online Library, Elsevier and SpringerLink.

Keywords: cancer biomarkers; electrochemical sensing; ovarian cancer; photoelectrochemical immunosensors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest.

Figures

Figure 1
Figure 1
Basic components of a typical EC immunosensor.
Figure 2
Figure 2
Construction steps of AuNPs/CNOs/SWCTNs/CS/anti–CEA biosensor. SWCNTs: single–walled carbon nanotubes; CNOs: carbon nano–onions; CS: chitosan; BSA: Bovine serum albumin. Reprinted with permission from [42], published by Elsevier, 2018.
Figure 3
Figure 3
Schematic illustration of the fabrication procedure for CEA immunosensor. GA: glutaraldehyde; Ab: antibody; BSA: bovine serum albumin. Reprinted with permission from [43], published by The Royal Society of Chemistry, 2020.
Figure 4
Figure 4
Electrospinning of core–shell honey nanofibers (HNF) onto the surface of a carbon–paste electrode (CPE) and preparation procedure of MWCNTs/GNPs/HNF/CPE based biosensor. MWCNTs: multi wall carbon nanotubes; GNPs: gold nanoparticles. Reprinted with permission from [46], published by Elsevier, 2020.
Figure 5
Figure 5
Schematic illustration of the fabrication process of CS–MWCNT–Fe3O4 based immunosensor for electrochemical detection of CA19–9 antigen. CS: chitosan; MWCNT: multiwalled– carbon nanotube; Fe3O4: magnetite nanoparticles; Ab: antibody; Ag: antigen. Reprinted with permission from [55], published by Elsevier, 2021.
Figure 6
Figure 6
Fabrication process of electrochemical immunosensor for CA 19–9 detection. CHIT: chitosan; GA: glutaraldehyde; BSA: bovine serum albumin; Zn-Co-S@ G: binary transition metal sulfide (Zn-Co-S) doped with graphene (G) [53].
Figure 7
Figure 7
The schematic representation of chitosan and carbon black composite based electrochemical immunosensor. Step 1: modification of electrode with glutaraldehyde; step 2: immobilization of antibody; step 3: blocking with BSA; step 4: antigen capturing. Reprinted with permission from [69], published by Elsevier, 2018.
Figure 8
Figure 8
Steps in the fabrication of EC immunosensor. PGE: Pencil graphite electrode; Ab: antibody. Reprinted with permission from [75], published by Elsevier, 2021.
Figure 9
Figure 9
Step–by–step fabrication of electrochemical immunosensor. Reprinted with permission from [89], published by Elsevier, 2016.
Figure 10
Figure 10
SPGE/poly(3–HPA)/anti–CA 125 Immunosensor construction process. Reprinted with permission from [90], published by Elsevier, 2020.
Figure 11
Figure 11
Procedure for developing BSA/anti–HER–2/APTES/MoO3@RGO/ITO immunosensor. RGO: reduced graphene oxide; APTES: (3–aminopropyl) triethoxysilane; BSA: Bovine serum albumin; ITO: indium tin oxide electrode; MoO3@RGO: graphene oxide doped with molybdenum trioxide. Reprinted with permission from [94], published by American Chemical Society, 2019.
Figure 12
Figure 12
Schematic illustration of the construction process of an immunosensor. Reprinted with permission from [95], published by Elsevier, 2020.
Figure 13
Figure 13
The schematic illustration of the fabrication procedure for CEA immunosensor.GO- NH2: amine–doped graphene oxide; Ab1: primary antibody; Ab2: secondary antibody; Fc: feroccene; Ox: oxidation; Re: reduction [108].
Figure 14
Figure 14
Illustrative fabrication process of carcinoembryonic antigen (CEA) sandwich immunosensor. Ab1: capture antibody; Ab2: secondary antibody; 3DPt/HGO: 3D porous graphene–oxide–supported platinum metal nanoparticles; GCE: glass carbon electrode [113].
Figure 15
Figure 15
The preparation process of Au@Pt DNs/NG/Cu2+–Ab2 and schematic illustration of the sandwich–type EC immunosensor. (A): Probe preparation process; (B): Electrode modification process for the capturing of antigen and probe. Au@PDA: polydopamine doped Au nanoparticles; Au@PtDNs: cubic Au doped with Pt dendritic nanomaterials; NG: nitrogen–doped graphene. Reprinted with permission from [114], published by Elsevier, 2018.
Figure 16
Figure 16
Schematic representation of the fabrication process for Ab2 label and sandwich–type electrochemical immunosensor for AFP detection. (A): Probe preparation process; (B): Electrode modification process for the capturing of antigen and probe. PDA–PR–MCS: polydopamine–decorated phenolic resin microporous carbon spheres; PR–MCS: phenolic resin microporous carbon spheres. Reprinted with permission from [118], published by Elsevier, 2018.
Figure 17
Figure 17
Electrochemical immunosensing process for detecting p53. PEDOT: PSS: poly (3, 4–ethylenedioxythiophene): polystyrenesulfonate; DAP: 2, 3–diaminophenazine; ZIF–8: Zeolitic Imidazolate framework-8; Ab1: primary antibody; Ab2: secondary antibody. Reprinted with permission from [119], published by Elsevier, 2020.
Figure 18
Figure 18
Illustration of the preparation of the electrochemical sandwich–type immunosensor using HRP enzyme for CA15–3 detection. (a): preparation process of Au nanoparticles and reduced graphene oxide (Au−rGO) nanocomposite through electrochemical reduction; (b): fabrication of the sensor; (b1): reduction of H2O2 by horseradish peroxidase (HRP), using hydroquinone (HQ) as electron mediator: (b2): redox process. Reprinted with permission from [120], published by Springer–Verlag GmbH Austria, 2021.
Figure 19
Figure 19
Fabrication scheme for a sandwich–type EC immunosensor and a DPV chart showing the level of attached electrochemical tracer (Cd2+) on the AuNPs (GNPs). Reprinted with permission from [122], published by Springer–Verlag GmbH Germany, 2018.
Figure 20
Figure 20
The construction steps in P5FIn/erGO based PEC immunosensor. GO: graphene oxide; Ab: antibody; P5Fln: poly (5–formylindole); 5Fln: 5–formylindole. Reprinted with permission from [135], published by Elsevier, 2018.
Figure 21
Figure 21
Schematic diagram of the fabrication procedure of a PEC immunosensor and possible charge transfer mechanism at WO3/Au/CdS interface in the presence of ascorbic acid (AA) as electron donor. e: electron; h: hole; PRET: Plasmon resonance energy transfer. Reprinted with permission from [136], published by Elsevier, 2018.
Figure 22
Figure 22
Schematic Illustration for the Detection Mechanism of CdS/PdPt–Based PEC biosensor and band structure of the PEC system under illumination. e: electron; h: hole: VB: valence band; CB: conduction band: Eg: energy gap. Reprinted with permission from [140], published by American Chemical Society, 2021.
Figure 23
Figure 23
Schematic processes involved in the photoelectrochemical immunoassay of CEA. (A): Fabrication process of the biosensor and photocurrent response; (B): Photoelectric conversion of C3N4–BiOCl; (C): mechanism of Cu2+ -quenched photocurrent of C3N4–BiOCl in the presence of L-cys. Reprinted with permission from [27], published by Springer–Verlag GmbH Austria, 2019.
Figure 24
Figure 24
Schematic illustration and electron transfer mechanism of the PEC immunosensor. e: electron; h: hole: AA: ascorbic acid; AAP: ascorbic acid 2–phosphate; Ag: antigen; Ab1: primary antibody; Ab2: Secondary antibody. Reprinted with permission from [28], published by Elsevier, 2019.
Figure 25
Figure 25
Schematic development process of the immunosensor (A) and photocurrent activity of ZnO/Ag2S nanocomposites (B). VB: valence band; CB: conduction band; e: electron [149].
Figure 26
Figure 26
Construction process of the photoelectrochemical immunoassay for CA19–9 detection and photogenerated electron–hole transfer mechanism of the immunosensor for target antigen (Ag) detection. AA: ascorbic acid; e: electron; Ab1: primary antibody; Ab2: secondary antibody. Reprinted with permission from [154], published by Elsevier, 2015.
Figure 27
Figure 27
Procedure for the fabrication of Photocathode–Based Immunosensor ITO/Bi2+xWO6/Ab/BSA/HE4. CE: counter electrode; RE: reference electrode; WE: working electrode; Ab: antibody; Ag: antigen. Reprinted with permission from [156], published by American Chemical Society, 2020.
Figure 28
Figure 28
Preparation procedure of Cu–CP–anti–CEA, Pb–CP–anti–CA199, Cd–CP–anti–CA125 and Zn–CP–anti–CA242 immunosensing probes (A) and the fabrication steps involved in the sandwich–type immunosensor (B). CP: chitosan–poly (acrylic acid) nanospheres; Cu-CP: Cu doped with chitosan–poly (acrylic acid) nanospheres; Pb-CP: Pb doped with chitosan–poly (acrylic acid) nanospheres; Cd-CP: Cd doped with chitosan–poly (acrylic acid) nanospheres; GA: glutaraldehyde; chit-Au: chitosan–decorated AuNPs; SWV: square wave voltammetry. Reprinted with permission from [165], published by Elsevier, 2016.

Similar articles

Cited by

References

    1. Arjmand M., Avval F. Clinical biomarkers for detection of ovarian cancer. J. Mol. Cancer. 2019;2:3–7.
    1. Centers for Disease Control and Prevention Basic Information About Ovarian Cancer. [(accessed on 26 June 2022)];2021 Available online: www.cdc.gov/cancer/ovarian/basic_info/index.htm.
    1. Kamal R., Hamed S., Mansour S.M., Mounir Y., Sallam S.A. Ovarian cancer screening—Ultrasound; impact on ovarian cancer mortality. Br. J. Radiol. 2018;91:20170571. doi: 10.1259/bjr.20170571. - DOI - PMC - PubMed
    1. Manasa G., Mascarenhas R.J., Shetti N.P., Malode S.J., Aminabhavi T.M. Biomarkers for Early Diagnosis of Ovarian Carcinoma. ACS Biomater. Sci. Eng. 2022;8:2726–2746. doi: 10.1021/acsbiomaterials.2c00390. - DOI - PubMed
    1. Gizaw M., Parkin D.M., Stöter O., Korir A., Kamate B., Liu B., Bojang L., N’Da G., Manraj S.S., Bukirwa P., et al. Trends in the incidence of ovarian cancer in sub-Saharan Africa. Int. J. Cancer. 2023;152:1328–1336. doi: 10.1002/ijc.34335. - DOI - PubMed

Substances